Invesco Ltd. - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 209 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.6%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$34,733,082
-5.3%
340,654
-15.6%
0.01%
-10.0%
Q1 2023$36,691,311
+971.9%
403,556
+347.9%
0.01%
+900.0%
Q4 2022$3,423,051
+402.7%
90,104
+232.4%
0.00%
Q3 2022$681,000
-16.3%
27,107
+1.2%
0.00%
Q2 2022$814,000
-55.7%
26,777
-52.3%
0.00%
Q1 2022$1,839,000
-96.9%
56,112
-97.5%
0.00%
-100.0%
Q4 2021$60,134,000
-82.6%
2,280,409
-33.7%
0.01%
-84.1%
Q3 2021$345,978,000
-13.0%
3,438,804
+22.4%
0.09%
-10.2%
Q2 2021$397,659,000
+94.0%
2,809,716
+36.6%
0.10%
+78.2%
Q1 2021$205,019,000
-6.8%
2,056,360
+15.6%
0.06%
-14.1%
Q4 2020$219,979,000
+301.3%
1,779,475
+216.3%
0.06%
+236.8%
Q3 2020$54,812,000
+560.6%
562,631
+958.0%
0.02%
+533.3%
Q2 2020$8,297,000
+3491.8%
53,178
+3234.0%
0.00%
Q1 2020$231,000
-97.8%
1,595
-96.9%
0.00%
-100.0%
Q4 2019$10,618,000
+500.2%
51,937
+177.0%
0.00%
Q2 2019$1,769,000
+11.5%
18,750
+1.0%
0.00%
-100.0%
Q1 2019$1,586,000
+560.8%
18,558
+333.4%
0.00%
Q4 2018$240,0004,2820.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders